{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:14:01Z","timestamp":1787501641347,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.biochi.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:26:15Z","timestamp":1780417575000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Guggulsterone as a modulator of the microbiota\u2013bile acid\u2013FXR axis: Molecular mechanisms and therapeutic potential in metabolic ageing"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0650-6745","authenticated-orcid":false,"given":"Alexander","family":"Ravikumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0792-392X","authenticated-orcid":false,"given":"Sarvesh","family":"Sabarathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biochi.2026.06.001_bib1","first-page":"159","article-title":"Bile acid and cholesterol metabolism in atherosclerotic cardiovascular disease and therapy","volume":"5","author":"Chiang","year":"2020","journal-title":"Cardiol."},{"key":"10.1016\/j.biochi.2026.06.001_bib2","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biochi.2026.06.001_bib3","article-title":"Cholesterol metabolism: physiological regulation and diseases","volume":"5","author":"Guo","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.biochi.2026.06.001_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biochi.2026.06.001_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1515\/mr-2024-0020","article-title":"Dysregulated bile acid homeostasis: unveiling its role in metabolic diseases","volume":"4","author":"Wang","year":"2021","journal-title":"Mediev. Rev."},{"key":"10.1016\/j.biochi.2026.06.001_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biochi.2026.06.001_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biochi.2026.06.001_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.biochi.2026.06.001_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.immuni.2025.02.003","article-title":"Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis","volume":"58","author":"Zhang","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.biochi.2026.06.001_bib10","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.21037\/jtd-24-734","article-title":"Farnesoid X receptor (FXR) as a potential therapeutic target for lung diseases: a narrative review","volume":"16","author":"Cao","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.biochi.2026.06.001_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70028","article-title":"Enhancing human gut health: global innovations in dysbiosis management","volume":"4","author":"El Boukhari","year":"2025","journal-title":"iMeta"},{"key":"10.1016\/j.biochi.2026.06.001_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biochi.2026.06.001_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/microorganisms3040641","article-title":"The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5","volume":"3","author":"Baars","year":"2015","journal-title":"Microorganisms"},{"key":"10.1016\/j.biochi.2026.06.001_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1197847","article-title":"Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice","volume":"14","author":"Wei","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biochi.2026.06.001_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2232143","article-title":"Gut microbiota-related bile acid metabolism-FXR\/TGR5 axis impacts the response to anti-\u03b14\u03b27-integrin therapy in humanized mice with colitis","volume":"15","author":"Han","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biochi.2026.06.001_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202400792","article-title":"Effects of natural polysaccharides on the gut microbiota related to human metabolic health","volume":"69","author":"Huang","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biochi.2026.06.001_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.155931","article-title":"The heart of the matter: how gut microbiota-targeted interventions influence cardiovascular diseases","volume":"269","author":"Abavisani","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.biochi.2026.06.001_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.biochi.2026.06.001_bib19","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.5604\/01.3001.0010.5672","article-title":"The role of the gut microbiota in bile acid metabolism","volume":"16","author":"Ram\u00edrez-P\u00e9rez","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.biochi.2026.06.001_bib20","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2172671","article-title":"Bile acids as modulators of gut microbiota composition and function","volume":"15","author":"Larabi","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.biochi.2026.06.001_bib21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.biochi.2026.06.001_bib22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile acids as hormones: the FXR-FGF15\/19 pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.biochi.2026.06.001_bib23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12072-023-10636-4","article-title":"FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence","volume":"18","author":"Simbrunner","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.biochi.2026.06.001_bib24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.biochi.2026.06.001_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.biochi.2026.06.001_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biochi.2026.06.001_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12070647","article-title":"Farnesoid X receptor, bile acid metabolism, and gut microbiota","volume":"12","author":"Mori","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.biochi.2026.06.001_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.reth.2025.08.011","article-title":"Microbiome-derived bile acids as endogenous regenerative mediators in liver repair","volume":"30","author":"Pandey","year":"2025","journal-title":"Regen. Ther."},{"key":"10.1016\/j.biochi.2026.06.001_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1155\/2012\/538452","article-title":"The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease","volume":"26","author":"Stojancevic","year":"2012","journal-title":"Can. J. Gastroenterol."},{"key":"10.1016\/j.biochi.2026.06.001_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.biochi.2026.06.001_bib31","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s11739-023-03343-3","article-title":"The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease","volume":"18","author":"Di Ciaula","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.biochi.2026.06.001_bib32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10620-020-06715-3","article-title":"Bile acid signaling in inflammatory bowel diseases","volume":"66","author":"Fiorucci","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biochi.2026.06.001_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093143","article-title":"Bile acid-gut microbiota axis in inflammatory bowel disease: from bench to bedside","volume":"13","author":"Yang","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.biochi.2026.06.001_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1021924","article-title":"Bile acids as inflammatory mediators and modulators of intestinal permeability","volume":"13","author":"Calzadilla","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biochi.2026.06.001_bib35","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.3748\/wjg.v20.i37.13493","article-title":"Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease","volume":"20","author":"Xu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biochi.2026.06.001_bib36","article-title":"Farnesoid X receptor agonists as therapeutic target for cardiometabolic diseases","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biochi.2026.06.001_bib37","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.bbalip.2006.09.018","article-title":"Effects of FXR in foam-cell formation and atherosclerosis development","volume":"1761","author":"Guo","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biochi.2026.06.001_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1582-4934.2009.00997.x","article-title":"FXR an emerging therapeutic target for the treatment of atherosclerosis","volume":"14","author":"Mencarelli","year":"2010","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biochi.2026.06.001_bib39","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.3748\/wjg.v29.i27.4252","article-title":"Bile acids and their receptors: potential therapeutic targets in inflammatory bowel disease","volume":"29","author":"Long","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.biochi.2026.06.001_bib40","article-title":"A review on guggulu formulations used in ayurveda","volume":"32014","author":"Tomar","year":"2014","journal-title":"Annals of Ayurvedic Medicine"},{"key":"10.1016\/j.biochi.2026.06.001_bib41","first-page":"22","article-title":"Cultivation and conservation of Guggulu (commiphora mukul)","volume":"29","author":"Thosar","year":"2009","journal-title":"Ancient Sci. Life"},{"key":"10.1016\/j.biochi.2026.06.001_bib42","article-title":"Pharmacology and phytochemistry of oleo-gum resin of Commiphora wightii (Guggulu)","volume":"2015","author":"Sarup","year":"2015","journal-title":"Sci. Tech. Rep."},{"key":"10.1016\/j.biochi.2026.06.001_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1527-3466.2007.00023.x","article-title":"Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits","volume":"25","author":"Deng","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.biochi.2026.06.001_bib44","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3389\/fphar.2018.00686","article-title":"Googling the guggul (Commiphora and Boswellia) for prevention of chronic diseases","volume":"9","author":"Kunnumakkara","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biochi.2026.06.001_bib45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.37349\/etat.2020.00019","article-title":"Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer","volume":"1","author":"Girisa","year":"2020","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.biochi.2026.06.001_bib46","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1074\/jbc.M209323200","article-title":"Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump","volume":"278","author":"Cui","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biochi.2026.06.001_bib47","article-title":"Antagonizing the bile-acid receptor","volume":"1","author":"Brazil","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biochi.2026.06.001_bib48","doi-asserted-by":"crossref","first-page":"Fso803","DOI":"10.2144\/fsoa-2022-0020","article-title":"The role of guggulsterone on the NF-\u03baB pathway in inflammatory bowel disease: preclinical evidence","volume":"8","author":"Priya","year":"2022","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.biochi.2026.06.001_bib49","first-page":"618","article-title":"Farnesoid X receptor regulators from natural products and their biological function","volume":"43","author":"Wan","year":"2023","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.biochi.2026.06.001_bib50","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1210\/mend.16.7.0894","article-title":"The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor","volume":"16","author":"Wu","year":"2002","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.biochi.2026.06.001_bib51","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-291X(03)00551-5","article-title":"Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene","volume":"304","author":"Owsley","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biochi.2026.06.001_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111678","article-title":"Recent advances on FXR-targeting therapeutics","volume":"552","author":"Panzitt","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biochi.2026.06.001_bib53","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The farnesoid X receptor","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biochi.2026.06.001_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12030550","article-title":"Double trouble: how microbiome dysbiosis and mitochondrial dysfunction drive non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"12","author":"Bahitham","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.biochi.2026.06.001_bib55","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1039\/C9MD00264B","article-title":"Dissecting the allosteric FXR modulation: a chemical biology approach using guggulsterone as a chemical tool","volume":"10","author":"Passeri","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.biochi.2026.06.001_bib56","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/501739","article-title":"Regulation of bile acid and cholesterol metabolism by PPARs","volume":"2009","author":"Li","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.biochi.2026.06.001_bib57","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/jpet.103.064329","article-title":"Guggulsterone activates multiple nuclear receptors and induces CYP3A gene expression through the pregnane X receptor","volume":"310","author":"Brobst","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biochi.2026.06.001_bib58","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1124\/jpet.106.113837","article-title":"The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism","volume":"320","author":"Deng","year":"2007","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.biochi.2026.06.001_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2025.100435","article-title":"The frontier of health: exploring therapeutic potentials of the microbiome","volume":"31","author":"Abavisani","year":"2025","journal-title":"PharmaNutrition"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908426001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:40:13Z","timestamp":1781300413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908426001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":59,"alternative-id":["S0300908426001331"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2026.06.001","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guggulsterone as a modulator of the microbiota\u2013bile acid\u2013FXR axis: Molecular mechanisms and therapeutic potential in metabolic ageing","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}